These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cutaneous malignancy and human immunodeficiency virus disease. Wilkins K; Turner R; Dolev JC; LeBoit PE; Berger TG; Maurer TA J Am Acad Dermatol; 2006 Feb; 54(2):189-206; quiz 207-10. PubMed ID: 16443048 [TBL] [Abstract][Full Text] [Related]
10. Dermatologic manifestations of HIV infection. Maurer TA Top HIV Med; 2005 Dec-2006 Jan; 13(5):149-54. PubMed ID: 16377853 [TBL] [Abstract][Full Text] [Related]
11. New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B. Soriano V; Vispo E; Barreiro P AIDS; 2011 Apr; 25(7):1013-4. PubMed ID: 21487255 [No Abstract] [Full Text] [Related]
12. Approach to the treatment of cutaneous malignancy in HIV-infected patients. Wilkins K; Dolev JC; Turner R; LeBoit PE; Berger TG; Maurer TA Dermatol Ther; 2005; 18(1):77-86. PubMed ID: 15842615 [TBL] [Abstract][Full Text] [Related]
15. A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. Kendall MA; Andersen JW; van der Horst C Contemp Clin Trials; 2006 Jun; 27(3):287-94. PubMed ID: 16545621 [TBL] [Abstract][Full Text] [Related]
16. Anaplastic Kaposi sarcoma resembling epithelioid angiosarcoma in an HIV-positive man. Craddock KJ; Labonte S; Ghazarian D Eur J Dermatol; 2008; 18(3):358-9. PubMed ID: 18474484 [No Abstract] [Full Text] [Related]